RETRACTION article

Front. Mol. Biosci., 11 September 2024

Sec. Molecular Diagnostics and Therapeutics

Volume 11 - 2024 | https://doi.org/10.3389/fmolb.2024.1491755

Retraction: Identification of a novel ferroptosis inducer for gastric cancer treatment using drug repurposing strategy

  • Frontiers Media SA, Lausanne, Switzerland

The journal retracts the 04 July 2022 article cited above.

Following publication, Frontiers was alerted to the presence of non-verifiable cell line identifiers in this publication. Upon further examination, it was determined that core findings of this study were obtained using non-verifiable cell lines and/or cell lines known to be cross-contaminated with HeLa. This contamination compromises the data and conclusions of the article and the article has been retracted.

This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and do not agree to this retraction. This communication has been recorded by the publisher.

Summary

Keywords

gastric cancer, ferroptosis, HC-056456, Inducer, small molecules

Citation

Frontiers Editorial Office (2024) Retraction: Identification of a novel ferroptosis inducer for gastric cancer treatment using drug repurposing strategy. Front. Mol. Biosci. 11:1491755. doi: 10.3389/fmolb.2024.1491755

Received

05 September 2024

Accepted

05 September 2024

Published

11 September 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

11 - 2024

Updates

Copyright

*Correspondence: Frontiers Editorial Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics